| RS1569257917 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1569258293 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS1569258901 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS1569261319 |
CNKSR2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS1569263557 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1569263642 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1569263730 |
PLA2G6
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation |
| RS1569264087 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS1569264288 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1569265331 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1569265470 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1569265497 |
MID1
|
Health Risk |
Pathogenic |
X-linked Opitz G/BBB syndrome, X-linked Opitz G/BBB syndrome |
| RS1569268013 |
MID1
|
Health Risk |
Pathogenic |
X-linked Opitz G/BBB syndrome, X-linked Opitz G/BBB syndrome |
| RS1569268029 |
MID1
|
Health Risk |
Pathogenic |
X-linked Opitz G/BBB syndrome, Inborn genetic diseases |
| RS1569268048 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS1569268070 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS1569268878 |
NR0B1
|
Health Risk |
Pathogenic |
— |
| RS1569268919 |
NR0B1
|
Health Risk |
Likely pathogenic |
— |
| RS1569268976 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS1569269179 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS1569269195 |
NR0B1
|
Health Risk |
Pathogenic |
— |
| RS1569270016 |
MID1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569270035 |
MID1
|
Health Risk |
Pathogenic |
X-linked Opitz G/BBB syndrome, X-linked Opitz G/BBB syndrome |
| RS1569270890 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS1569271378 |
POLA1
|
Health Risk |
Pathogenic |
X-linked intellectual disability, van Esch type |
| RS1569271892 |
POLA1
|
Health Risk |
Pathogenic |
X-linked intellectual disability, van Esch type |
| RS1569272194 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1569272203 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1569272271 |
CNKSR2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1569272328 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Tooth agenesis |
| RS1569272528 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1569273900 |
KDM5C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569273905 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569274606 |
KDM5C
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1569277866 |
POLA1
|
Health Risk |
Pathogenic |
X-linked intellectual disability, van Esch type |
| RS1569277899 |
POLA1
|
Health Risk |
Pathogenic |
X-linked intellectual disability, van Esch type |
| RS1569278313 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Spastic paraplegia |
| RS1569279367 |
KDM5C
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS1569280138 |
POU3F4
|
Health Risk |
Pathogenic |
X-linked mixed hearing loss with perilymphatic gusher, X-linked mixed hearing loss with perilymphatic gusher |
| RS1569280197 |
POU3F4
|
Health Risk |
Likely pathogenic |
— |
| RS1569280235 |
POU3F4
|
Health Risk |
Pathogenic |
Autosomal recessive sensorineural hearing loss, Autosomal recessive sensorineural hearing loss |
| RS1569280385 |
POU3F4
|
Health Risk |
Pathogenic |
X-linked mixed hearing loss with perilymphatic gusher, X-linked mixed hearing loss with perilymphatic gusher |
| RS1569280986 |
SLC16A2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1569281032 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS1569281085 |
SLC16A2
|
Health Risk |
Pathogenic |
Allan-Herndon-Dudley syndrome, Spastic paraplegia |
| RS1569281190 |
SLC16A2
|
Health Risk |
Pathogenic |
— |
| RS1569281354 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS1569282905 |
OTC
|
Health Risk |
Pathogenic/Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS1569283243 |
CASK
|
Health Risk |
Likely pathogenic |
FG syndrome 4, Syndromic X-linked intellectual disability Najm type |
| RS1569285361 |
KDM5C
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS1569285562 |
KDM5C
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1569288603 |
CASK
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS1569290395 |
BRWD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 93 |
| RS1569290954 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS1569291215 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS1569291244 |
BTK
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia |
| RS1569291261 |
CASK
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Najm type, Congenital cerebellar hypoplasia |
| RS1569291627 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS1569291644 |
BTK
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia |
| RS1569291654 |
IQSEC2
|
Health Risk |
Pathogenic |
— |
| RS1569291699 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS1569292021 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1569292214 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS1569292649 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS1569292774 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS1569292810 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1569292813 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS1569292818 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS1569293252 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1569293253 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS1569293373 |
NF2
|
Health Risk |
Pathogenic |
Neoplasm, Neoplasm |
| RS1569293488 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1569294187 |
NF2
|
Health Risk |
Pathogenic |
Spindle cell sarcoma, Spindle cell sarcoma |
| RS1569295677 |
CASK
|
Health Risk |
Pathogenic/Likely pathogenic |
Syndromic X-linked intellectual disability Najm type, Congenital cerebellar hypoplasia |
| RS1569295678 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1569295916 |
NF2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1569296295 |
BTK
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked agammaglobulinemia, Inherited Immunodeficiency Diseases |
| RS1569297379 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1569297427 |
PHKA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1569298646 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1569300277 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS1569300538 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, PHKA2-related disorder |
| RS1569300687 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS1569301036 |
TAF1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS1569302194 |
CASK
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, CASK-related |
| RS1569302393 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1569302692 |
GLA
|
Health Risk |
Pathogenic |
— |
| RS1569302697 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1569302816 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS1569302887 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1569302982 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1569302985 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS1569303030 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1569303189 |
GLA
|
Health Risk |
Pathogenic |
— |
| RS1569303213 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1569303218 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1569303295 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1569303815 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1569303843 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1569304190 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Cardiovascular phenotype |